Schwab Gisela
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Schwab Gisela. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 40,000 | $4.20 | $168,000 | Jul 26, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 35,000 | $4.20 | $147,000 | Jul 21, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 100,000 | $1.90 | $190,000 | May 13, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Sale | 50,000 | $25.00 | $1,250,000 | Apr 26, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Sale | 50,000 | $23.00 | $1,150,000 | Apr 1, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Award / Grant | 72,885 | — | — | Mar 4, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 50,000 | $1.70 | $85,000 | Feb 17, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Tax Withholding | 2,858 | $21.91 | $62,619 | Feb 15, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Award / Grant | 9,745 | — | — | Feb 3, 2021 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Tax Withholding | 9,685 | $20.16 | $195,250 | Nov 15, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Award / Grant | 213,879 | — | — | Oct 22, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Tax Withholding | 2,517 | $21.58 | $54,317 | Sep 2, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 100,000 | $1.70 | $170,000 | Jun 4, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 100,000 | $1.70 | $170,000 | Apr 23, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Sale | 50,000 | $19.20 | $960,000 | Mar 4, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 40,000 | $5.51 | $220,400 | Feb 19, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 50,000 | $5.51 | $275,500 | Feb 7, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Sale | 50,000 | $17.96 | $898,000 | Jan 7, 2020 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Award / Grant | 15,592 | — | — | Dec 4, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 50,000 | $5.51 | $275,500 | Dec 3, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Tax Withholding | 2,583 | $16.51 | $42,645 | Nov 15, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 50,000 | $5.51 | $275,500 | Nov 4, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 30,000 | $5.51 | $165,300 | Oct 1, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Tax Withholding | 2,577 | $19.26 | $49,633 | Sep 12, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 63,109 | $7.18 | $453,123 | Apr 3, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 100,000 | $7.18 | $718,000 | Mar 25, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 100,000 | $5.56 | $556,000 | Feb 15, 2019 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Sale | 13,499 | $21.02 | $283,749 | Dec 3, 2018 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Tax Withholding | 2,479 | $17.45 | $43,259 | Nov 15, 2018 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Option Exercise | 12,000 | $5.04 | $60,480 | Nov 1, 2018 |
| EXEL | Pres, Prod Dev & Med Aff & CMO | Sale | 12,000 | $17.77 | $213,240 | Oct 1, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Sale | 22,500 | $18.53 | $416,925 | Sep 4, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 50,000 | $5.51 | $275,500 | Aug 17, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 22,500 | $5.50 | $123,750 | Aug 1, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Sale | 22,500 | $21.20 | $477,000 | Jul 2, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Sale | 22,500 | $20.80 | $468,000 | Jun 1, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Sale | 14,700 | $23.47 | $345,009 | May 3, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 14,591 | $7.18 | $104,763 | Apr 6, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 7,293 | $4.42 | $32,235 | Mar 1, 2018 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Tax Withholding | 2,609 | $24.75 | $64,573 | Nov 15, 2017 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Award / Grant | 75,000 | — | — | Oct 3, 2017 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Sale | 33,333 | $23.68 | $789,325 | Sep 28, 2017 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 12,501 | $5.04 | $63,005 | May 15, 2017 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 89,910 | $9.91 | $891,008 | May 1, 2017 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 10,090 | $9.91 | $99,992 | Apr 17, 2017 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 17,707 | $4.42 | $78,265 | Mar 15, 2017 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Option Exercise | 22,000 | $8.99 | $197,780 | Dec 1, 2016 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Sale | 22,000 | $15.00 | $330,000 | Nov 9, 2016 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Award / Grant | 20,000 | — | — | Sep 22, 2016 |
| EXEL | Pres Prod Dev & Med Aff & CMO | Sale | 131,155 | $10.98 | $1,440,082 | Aug 31, 2016 |